pyrazolanthrone has been researched along with Autoimmune Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dakhama, A; Domenico, J; Gelfand, EW; Joetham, A; Ohnishi, H; Okamoto, M; Schedel, M; Takeda, K | 1 |
1 other study(ies) available for pyrazolanthrone and Autoimmune Disease
Article | Year |
---|---|
Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation.
Topics: Animals; Anthracenes; Asthma; Autoimmune Diseases; Cell Proliferation; Enzyme Activation; Female; Glucocorticoid-Induced TNFR-Related Protein; Immune Tolerance; Lung; MAP Kinase Kinase 4; MAP Kinase Kinase 7; MAP Kinase Signaling System; Mice; Mice, Knockout; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; T-Lymphocytes, Regulatory | 2012 |